At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Restylane Kyssedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Clinical Study to Evaluate Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects
In Brief
A clinical study evaluating Restylane Kysse for Lip Augmentation. Completed, enrolled 22 participants across 3 sites.
Detailed Summary
Open-label, phase IV, post-marketing study to evaluate aesthetic improvement in Chinese subjects after treatment with Restylane Kysse.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLip Augmentation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedApr 2022
Enrollment StartJun 2022
Primary CompletionOct 2024
Study CompletionNov 2024
TodayJul 2026
First PostedApr 25, 2022
Enrollment StartJun 13, 2022
Primary CompletionOct 25, 2024
Study CompletionNov 7, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.2 years ago
Interventions
Restylane Kyssedevice
Hyaluronic Acid: Injectable gel for lip augmentation and the correction of upper perioral rhytids